2seventy Bio Inc (TSVT) Return on Investment ROI from the first quarter of 2025 to first quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket
 


2seventy Bio Inc   (NASDAQ: TSVT)


2seventy Bio Inc's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is 2seventy Bio Inc's ROI in the first quarter of 2025?
2seventy Bio Inc recorded a cumulative net loss of $-4 million during 12 months ending in the first quarter of 2025, resulting in a negative return on investment (ROI) of -0.91%.

Within the Healthcare sector 189 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2025 quarter, so far to 2486, from total ROI ranking in the fourth quarter of 2024 at 2840.

Definition and Formula of Return on Investment



Return On Investment (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
Y / Y Investment Change TTM -16.58 % -23.6 % -23.12 % -20.33 % -15.3 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 439 439 460 471 451
Return On Investment (TTM) -0.91 % -12.58 % -20.04 % -31.25 % -41.19 %
TSVT's Overall Ranking # 2486 # 2840 # 2683 # 2795 # 2842
Seq. Investment Change TTM -0.66 % -3.51 % -5.65 % -7.76 % -9.02 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -4 -57 -95 -156 -223




Return On Investment TSVT's Ranking
Within: No.
Industry # 58
Sector # 190
Overall # 2486

Return On Investment Statistics
High Average Low
-0.91 %
-27.36 %
-41.19 %
(Mar 31 2025)   (Mar 31 2024)



  News about 2seventy Bio Inc Return on Investment ROI

A Comprehensive Examination of the Legal Inquiry into 2seventy bio, Inc. and Its Implications for the Biotechnology S...

October 9, 2024

: The biotechnology sector continues to be a dynamic and volatile industry, characterized by rapid advancements in research and development juxtaposed against rigorous regulatory scrutiny and volatile market behaviors. A pertinent example of these fluctuations is evident in the recent investigation launched by the law firm Bronstein, Gewirtz and Grossman, LLC into potential securities misconduct within 2seventy bio, Inc. (NASDAQ: TSVT). This analysis intends to provide a comprehensive review of the ongoing investigation s implications for investors and the broader biotechnology industry.2seventy bio, Inc. a formidable player in the biotechnology realm, has recently come under the legal and financial microscope. Headquartered in Cambridge, Massachusetts, 2seventy bio has carved out a niche in cell and gene therapy fields that are not only at the forefront of contemporary medical innovation but are also areas fraught with regulatory and financial risk. The investigation spearheaded by Bronstein, Gewirtz and Grossman, LLC emerges amid growing concerns regarding potential discrepancies in the company’s communications with investors, corporate governance practices, and ethical transparency.






Financial Statements
2seventy Bio Inc's I. Quarter Investments $ 439 Millions TSVT's Balance sheet
2seventy Bio Inc's I. Quarter Income $ 0 Millions Quarterly TSVT's Income Statement
TSVT's Income by Division See TSVT's Income by Division


TSVT Annual Return On Investment (Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021

Total Investments in Millions 439 506 577 661 0
Y / Y Investment Growth -13.1 % -12.35 % -12.77 % - -
Net Income in Millions -57 -218 -254 -292 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -13.03 % -43.03 % -44.06 % -44.19 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TSVT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TSVT's Competitors
Subscribers only: Roi for 2seventy Bio Inc's Suppliers
Subscribers only: Return On Investment for TSVT's Customers

Other Ratios
TSVT's Roa TSVT's Inventory Turnover Ratio TSVT's Growth Rates TSVT's Dividend Statistics
TSVT's Profitability Ratios TSVT's Asset Turnover Ratio TSVT's Dividend Growth
TSVT's Roe TSVT's Valuation Ratios TSVT's Financial Strength Ratios TSVT's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI


Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.